MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with an initial focus on industrial safety applications in South America's mining sector, according to a recent article.
The biotechnology company recently appointed Chilean policy specialist Felipe Leyton to lead commercialization efforts in the region, signaling a transition from technology development to field implementation in large enterprise environments. Leyton brings experience in national drug policy and workplace safety, having helped design and implement Chile's 'Zero Tolerance' alcohol-impaired driving law as part of the country's alcohol prevention framework. He also played a role in establishing Chile's roadside drug testing program introduced in 2019. His appointment reflects MindBio's strategy of aligning technical development with regulatory and industry expertise in markets where impairment detection is closely tied to workplace safety and compliance requirements.
MindBio's AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI. Target environments include mining, aviation, construction, and law enforcement.
This move is significant for the mining industry, where impairment from drugs or alcohol can lead to serious accidents. By implementing voice-based detection, companies may improve safety compliance and reduce risks. The technology could also have broader applications in other high-risk industries such as aviation and construction, as well as in law enforcement for roadside testing.
For more details, the full article is available at https://ibn.fm/JBNVq. The latest news and updates relating to MBQIF are available in the company's newsroom at https://ibn.fm/MBQIF.
